0.8450
0.0000
(0.00%)
As of 8:00:23 AM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Governor Thomas G. Thompson | Executive Chairman | 141.07k | -- | 1942 |
Mr. Marlan D. Walker J.D. | Chief Executive Officer | 583.18k | -- | 1975 |
Mr. Joseph A. Ziegler | Principal Financial & Accounting Officer | 125.75k | -- | 1974 |
Mr. Douglas Steelman | Vice President of Market Access | -- | -- | -- |
TherapeuticsMD, Inc.
951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1
Description
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Corporate Governance
TherapeuticsMD, Inc.’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 8, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
TherapeuticsMD, Inc. Earnings Date
Recent Events
Recent Events Information Not Available